Navigation Links
PhRMA Statement on House Passage of Health Care Reform Bill
Date:11/8/2009

WASHINGTON, Nov. 8 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson released the following statement regarding the House health care reform bill:

"We are disappointed, but not surprised by today's vote -- an uneasiness echoed by millions of hardworking Americans as well as nearly half of the members of the U.S. House of Representatives who voted against the bill.

"While well intentioned, the bill -- as passed -- would have the unintended consequences of killing tens of thousands of jobs in our industry at a time when the American economy is struggling and unemployment has soared above 10 percent. This is absolutely the worst time to be putting additional strains on the economy with punishing job losses.

"Despite the shortcomings in the House legislation, we remain completely committed to helping the President and Congress pass comprehensive health care reform this year. We continue to be guided by a single-minded purpose: everyone in America -- not just some of us, but all of us -- should have access to high-quality, affordable health care coverage and services. Done in a smart way, health care reform will benefit patients, the economy and the future of our nation.

"From the beginning, we knew that this would be a long, contentious and oftentimes difficult process, but if health care reform is to be successful, it will require a shared sacrifice -- and we are prepared to do our part. We remain convinced that the approach taken by the Senate Finance Committee provides the best blueprint for comprehensive reform. As an editorial in today's Washington Post pointed out, 'The House will probably pass the bill. But there there's a lot of work to be done before its final enactment will be possible -- or desirable.'

"That's our take, too. This is a three-act play and a good critic doesn't write a review after the opening scenes. We are still hopeful that before the curtain comes down on health care reform, the Senate will seriously consider the impact any final legislation will have on U.S. jobs and innovation. Cutting-edge medicines have dramatically increased life expectancy rates in America and around the world and have allowed patients with cancer, heart disease, diabetes and other devastating chronic diseases to live longer, healthier and more productive lives.

"If we are going to cure cancer in our lifetime -- as President Obama has challenged us to do -- we believe health care reform must support medical progress and innovation in America. Saving money is important, but so is saving lives. In the end, we believe that thoughtful leaders will step up and recognize the overriding importance of striking the right balance. Among other things, we believe final health care reform legislation should provide for a fair period of data protection for innovative biologic medicines which hold the promise to revolutionize health care.

"What's crucial now is that we remain focused on the laudable goal of enacting comprehensive health care reform this year. In life, we get precious few opportunities to fundamentally improve the lives of people all across our great nation. Working together, this is our chance."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info

For more information on public health emergencies, visit http://www.rxresponse.org

SOURCE Pharmaceutical Research and Manufacturers of America


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DIA/FDA/PhRMA to Host Progression-Free Survival Oncology Workshop
2. National Medical Association Applauds President Obamas and Senator Baucuss Efforts to Work With PhRMA to Bring Down Health Care Costs and Advance Meaningful Reforms
3. PhRMA Statement on Medicare Part D Coverage Gap
4. PhRMA Launches Campaign to Raise Awareness of Success of Medicare Prescription Drug Benefit
5. PhRMA Statement on Healthcare Reform Coalition
6. American Slide Chart/Perrygraf "SlideGuides" and "SpinGuides" Help Drug Companies Satisfy New PhRMA Guidelines
7. PhRMA Honors Gardasil(r) Researchers With Discoverers Award
8. AstraZenecas David Brennan Elected PhRMA Board Chairman
9. PhRMA Statement on Expansion of SCHIP
10. DIA/FDA/PhRMA Drug Safety Conference: Planning the Lifecycle of Safety Evaluation
11. Revised PhRMA Marketing Code Calls for More Educational Materials for Health Care Providers and Staff - Anatstat Health Education Can Help
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV ... the much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream ... Each week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors ...
(Date:2/5/2016)... CA (PRWEB) , ... February 05, 2016 , ... ... to announce the addition of micro-needling services in their Napa Valley office. The ... founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of ...
(Date:2/5/2016)... Miami, Florida (PRWEB) , ... February 05, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – is poised to once again host, Swirl, A Wine Tasting Event ...
(Date:2/5/2016)... ... February 05, 2016 , ... Regular gym users know the routine: ... wait longer to access the treadmills. It’s a predictable trend. After the excesses of ... and get in shape by joining gyms, starting new walking or running routines, or ...
(Date:2/5/2016)... , ... February 05, 2016 , ... At its annual ... Patrick McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds former ... the Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat has ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016 Aethlon Medical, Inc. (Nasdaq: ... Chairman and CEO, will be presenting at Source Capital Group,s ... York, NY at 2:15 p.m. ET on Wednesday, ... Immunotherapy Panel discussion taking place at 3:15 p.m. ET. ... approximately one hour after the conclusion of the live event. ...
(Date:2/5/2016)... Feb. 5, 2016  Zimmer Biomet Holdings, Inc. (NYSE ... previously announced underwritten secondary offering of 11,027,558 shares of ... of affiliates of Blackstone and Goldman Sachs.  The shares ... price of $96.45 per share. The selling stockholders will ... Zimmer Biomet nor any of its directors, officers or ...
(Date:2/5/2016)... France , Germany ... and Israel ). It includes a 10-year epidemiology forecast ... segmented by age and sex in these markets. GD epidemiology report is ... in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends ... Germany , Italy , Spain ...
Breaking Medicine Technology: